Cabot Corporation (NYSE:CBT) Given Consensus Rating of “Hold” by Analysts

Cabot Corporation (NYSE:CBT) has received a consensus recommendation of “Hold” from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $80.25.

CBT has been the subject of a number of research reports. Mizuho increased their price target on Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Wall Street Zen lowered Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. JPMorgan Chase & Co. increased their price target on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Finally, UBS Group increased their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th.

Cabot Price Performance

Shares of Cabot stock opened at $80.86 on Friday. The stock has a 50 day moving average of $79.11 and a 200 day moving average of $73.00. Cabot has a 12 month low of $58.33 and a 12 month high of $89.46. The firm has a market cap of $4.17 billion, a PE ratio of 15.28, a PEG ratio of 10.96 and a beta of 0.82. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.31 million. During the same period in the prior year, the company earned $1.90 earnings per share. The firm’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts expect that Cabot will post 6.32 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio (DPR) is currently 35.73%.

Institutional Investors Weigh In On Cabot

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Fuller & Thaler Asset Management Inc. increased its holdings in Cabot by 5.6% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after purchasing an additional 124,613 shares during the period. State Street Corp increased its holdings in Cabot by 1.0% during the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after purchasing an additional 20,021 shares during the period. American Century Companies Inc. increased its holdings in Cabot by 8.4% during the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after purchasing an additional 140,665 shares during the period. Dimensional Fund Advisors LP increased its holdings in Cabot by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after purchasing an additional 79,499 shares during the period. Finally, Bank of America Corp DE increased its holdings in Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after purchasing an additional 63,080 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.